Ultima UG200 Chosen for 80,000-Sample UK Biobank Immune Study
This story is from 2026-10-19. It is preserved in the archive; the latest stories are on the live feed.
In an announcement dated October 19, 2026, Ultima Genomics said its UG200 Sequencing Platform has been selected to power a large-scale single-cell immune profiling study with IMU Biosciences and UK Biobank, covering an initial 80,000 blood samples from UK Biobank participants and producing a founda…
Read the full story at Unite.AI ↗
Timeline · 1 report
- 2026-10-19 07:29 · Unite.AI
Ultima UG200 Chosen for 80,000-Sample UK Biobank Immune Study